Sofosbuvir/Velpatasvir in Combination With Ribavirin for 24 Weeks Is Effective Retreatment for Patients Who Failed Prior NS5A-Containing DAA Regimens: Results of the Retreatment Study

Gane EJ, Shiffman ML, Etzkorn K, Morelli G, Stedman C, Davis MN, et al. Sofosbuvir/Velpatasvir in Combination With Ribavirin for 24 Weeks Is Effective Retreatment for Patients Who Failed Prior NS5A-Containing DAA Regimens: Results of the Retreatment Study. In 51st Annual Meeting of the European Association for the Study of the Liver (EASL). April 13-17. Barcelona, Spain; 2016.

Publication Type:

Conference Paper

Authors:

Edward J. Gane; Mitchell L. Shiffman; Kyle Etzkorn; Giuseppe Morelli; Catherine Stedman; Mitchell N. Davis; Federico Hinestrosa

Source:

51st Annual Meeting of the European Association for the Study of the Liver (EASL). April 13-17., Barcelona, Spain (2016)

Cited On:

Export Citation:
RIS Format
Top